Deutsch English Français

Contact

EP1899321

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...

News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...

Extract from the Register of European Patents

EP About this file: EP1899321

EP1899321 - HETEROARYL-SUBSTITUTED AMIDES COMPRISING A SATURATED LINKER GROUP, AND THEIR USE AS PHARMACEUTICALS [Right-click to bookmark this link]
Status	No opposition filed within time limit Status updated on 02.11.2012 Database last updated on 13.07.2024
Most recent event Tooltip	18.01.2013	Lapse of the patent in a contracting state New state(s): MC	published on 20.02.2013 [2013/08]
Applicant(s)	For all designated states SANOFI 54, rue La Boétie 75008 Paris / FR
	[N/P]
Former [2012/18]	For all designated states SANOFI 54 rue La Boétie 75008 Paris / FR
Former [2012/17]	For all designated states SANOFI 54, rue de la Boétie 75008 Paris / FR
Former [2011/30]	For all designated states SANOFI 174, Avenue de France 75013 Paris / FR
Former [2008/12]	For all designated states Sanofi-Aventis 174, Avenue de France 75013 Paris / FR
Inventor(s)	01 / STROBEL, Hartmut c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE
	02 / WOHLFART, Paulus c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE
	03 / ZOLLER, Gerhard c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE
	04 / WILL, David, William c/o Sanofi-Aventis Deutschland GmbH 65926 Frankfurt am Main / DE
	[2008/12]
Representative(s)	Kujath, Eckard Sanofi-Aventis Deutschland GmbH Global Intellectual Property Department Industriepark Höchst Gebäude K 703 65926 Frankfurt am Main / DE
	[N/P]
Former [2011/52]	Kujath, Eckard Sanofi-Aventis Deutschland GmbH Patent- und Lizenzabteilung Industriepark Höchst Gebäude K 801 65926 Frankfurt am Main / DE
Former [2008/12]	Kujath, Eckard Sanofi-Aventis Deutschland GmbH Patent- und Lizenzabteilung Industriepark Höchst Gebäude K 801 D-65926 Frankfurt am Main / DE
Application number, filing date	06754352.0	14.06.2006
	[2008/12]
	WO2006EP05706
Priority number, date	EP20050013870	28.06.2005 Original published format: EP 05013870
	[2008/12]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2007000246
	Date:	04.01.2007
	Language:	EN
	[2007/01]
	Type:	A1 Application with search report
	No.:	EP1899321
	Date:	19.03.2008
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 04.01.2007 takes the place of the publication of the European patent application.
	[2008/12]
	Type:	B1 Patent specification
	No.:	EP1899321
	Date:	28.12.2011
	Language:	EN
	[2011/52]
Search report(s)	International search report - published on:	EP	04.01.2007
Classification	IPC:	C07D401/06	[2008/12]
	CPC:	C07D213/40 (EP,US); C07D401/06 (EP,KR,US); A61P1/16 (EP); A61P11/06 (EP); A61P13/12 (EP); A61P15/10 (EP); (+) A61P19/10 (EP); A61P25/28 (EP); A61P27/02 (EP); A61P3/10 (EP); A61P43/00 (EP); A61P7/02 (EP); A61P9/00 (EP); A61P9/04 (EP); A61P9/06 (EP); A61P9/08 (EP); A61P9/10 (EP); A61P9/12 (EP); C07D213/65 (EP,US); C07D277/42 (EP,KR,US); C07D401/12 (EP,KR,US); C07D401/14 (EP,US); C07D413/06 (EP,US); C07D417/06 (EP,KR,US); C07D417/12 (EP,US) (-)
Designated contracting states	AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2008/12]
Extension states	AL	28.01.2008
	BA	28.01.2008
	HR	28.01.2008
	MK	28.01.2008
	RS	28.01.2008
Title	German:	HETEROARYLSUBSTITUIERTE AMIDE MIT GESÄTTIGTER VERBINDUNGSGRUPPE UND IHRE VERWENDUNG ALS PHARMAZEUTIKA	[2008/12]
	English:	HETEROARYL-SUBSTITUTED AMIDES COMPRISING A SATURATED LINKER GROUP, AND THEIR USE AS PHARMACEUTICALS	[2008/12]
	French:	AMIDES À SUBSTITUTION HÉTÉROARYLE COMPRENANT UN GROUPE DE LIAISON SATURÉ, ET LEUR UTILISATION EN TANT QUE PRODUITS PHARMACEUTIQUES	[2008/12]
Entry into regional phase	28.01.2008	National basic fee paid
	28.01.2008	Designation fee(s) paid
	28.01.2008	Examination fee paid
Examination procedure	13.02.2007	Request for preliminary examination filed International Preliminary Examining Authority: EP
	28.01.2008	Examination requested [2008/12]
	29.07.2008	Despatch of a communication from the examining division (Time limit: M06)
	07.02.2009	Reply to a communication from the examining division
	17.01.2011	Despatch of a communication from the examining division (Time limit: M02)
	19.03.2011	Reply to a communication from the examining division
	12.07.2011	Communication of intention to grant the patent
	16.11.2011	Fee for grant paid
	16.11.2011	Fee for publishing/printing paid
Divisional application(s)	The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 29.07.2008
Opposition(s)	01.10.2012	No opposition filed within time limit [2012/49]
Fees paid	Renewal fee
	30.06.2008	Renewal fee patent year 03
	30.06.2009	Renewal fee patent year 04
	30.06.2010	Renewal fee patent year 05
	13.06.2011	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition Tooltip	IS	28.04.2012
	MC	30.06.2012
	[2013/08]
Former [2012/34]	IS	28.04.2012
Cited in	International search	[X]WO02070520 (BAYER AG [DE], et al) [X] 1-8,10-12 * examples 21,25; claims 1-4 *;
		[A]US2003055093 (STROBEL HARTMUT [DE], et al) [A] 1-16* the whole document *;
		[X]WO03094845 (BRISTOL MYERS SQUIBB CO [US], et al) [X] 1-8 * example 82 *;
		[DA]WO2004014842 (AVENTIS PHARMA GMBH [DE]) [DA] 1-16 * claims 1,2,9,10; table 1 *;
		[X]WO2004060890 (AMGEN INC [US]) [X] 1-8 * example 51 *
	by applicant	JPS4429656B
		DE1913471
		US3655684
		GB1341375
		EP0200024
		US5190589
		US5292732
		US5547972
		WO02070520
		JP2004262890
		WO2004089903
		WO2004094425
		- LIPINSKI ET AL., J. MED. CHEM., (1986), vol. 29, page 2154
		- HAGEN ET AL., PHARMAZIE, (1990), vol. 45, page 343
		- MEIJERE ET AL., ANGEW. CHEM. INT. ED., (1994), vol. 33, page 2379
		- KOTHA ET AL., TETRAHEDRON, (2002), vol. 58, page 9633
		- TILLEY ET AL., J. ORG. CHEM., (1988), vol. 53, page 386

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.1.24; 35p